Bay Colony Advisors’s Biogen BIIB Stock Holding History

Bay Colony Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,620	Closed	-$416K	–	396
2023 Q3	$416K	Buy	+1,620	New	+$433K	0.1%	194
2018 Q3	–	Sell	-275	Closed	-$80K	–	276
2018 Q2	$80K	Buy	+275	New	+$77.3K	0.06%	288

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bay Colony Advisors's BIIB Position: Q4 2023 in Review

Bay Colony Advisors sold out of Biogen (BIIB) in Q4 2023, closing a stake of 1,620 shares — an estimated $416K sold.

Bay Colony Advisors first reported a position in BIIB in Q2 2018 and held it in 2 quarters. The position peaked at $416K in Q3 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

Bay Colony Advisors reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
Bay Colony Advisors sold 1,620 Biogen shares in Q4 2023, an estimated $416K.
Bay Colony Advisors first reported a position in Biogen in Q2 2018 and held it in 2 quarters.
Bay Colony Advisors's Biogen position peaked at $416K in Q3 2023.
1,002 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Bay Colony Advisors's 13F filing for Q4 2023, filed 30 Jan 2024.